| Not Yet Recruiting | A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet NCT07285967 | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Phase 1 |
| Not Yet Recruiting | MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function NCT03606538 | Lykos Therapeutics | Phase 1 |
| Recruiting | Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcu NCT07422285 | Amgen | Phase 1 |
| Completed | Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single S NCT07312643 | RECORDATI GROUP | Phase 1 |
| Completed | Study of BB-025, Alone and After BB-031, in Healthy Volunteers NCT07202663 | Basking Biosciences, Inc. | Phase 1 |
| Recruiting | Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults NCT07060209 | Haiphong University of Medicine and Pharmacy | Phase 1 |
| Not Yet Recruiting | A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23 NCT06916169 | Ahn-Gook Pharmaceuticals Co.,Ltd | Phase 1 |
| Completed | A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimina NCT07102095 | Bayer | Phase 1 |
| Completed | Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers NCT06854783 | Tiamat Australia Pty Ltd | Phase 1 |
| Recruiting | High Potency Cannabis: Acute and Protracted Effects NCT06859723 | University of California, Los Angeles | Phase 1 |
| Not Yet Recruiting | Single Ascending Dose and Multiple Ascending Dose Study of AVR-48 NCT06847698 | AyuVis Research, Inc. | Phase 1 |
| Completed | A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects NCT07126249 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Active Not Recruiting | A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a NCT06921590 | Alzamend Neuro, Inc. | Phase 1 |
| Recruiting | Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers. NCT06752122 | RNATICS GmbH | Phase 1 |
| Recruiting | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination NCT06733675 | Basilea Pharmaceutica | Phase 1 |
| Not Yet Recruiting | Pharmacokinetics of Oral Calcium Carbonate in Parturients NCT06650930 | Stanford University | EARLY_Phase 1 |
| Completed | A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects NCT06694948 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Unknown | Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T NCT05617651 | Il-Yang Pharm. Co., Ltd. | Phase 1 |
| Recruiting | Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102) NCT06500793 | Ensysce Biosciences | Phase 1 |
| Completed | Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Particip NCT06665555 | Basilea Pharmaceutica | Phase 1 |
| Not Yet Recruiting | Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients NCT06666998 | Sichuan Provincial People's Hospital | — |
| Recruiting | Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults NCT06574100 | University of Saskatchewan | Phase 1 |
| Completed | The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment NCT06562946 | Abbisko Therapeutics Co, Ltd | Phase 1 |
| Completed | Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers NCT06480981 | DemeRx NB | Phase 1 |
| Active Not Recruiting | PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine NCT06519045 | Intelligent Bio Solutions Inc. | — |
| Active Not Recruiting | Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC NCT06471868 | Il-Yang Pharm. Co., Ltd. | Phase 1 |
| Recruiting | Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects NCT06379958 | Modern Biosciences Ltd | Phase 1 |
| Completed | Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia NCT06425757 | Xie Kangjie | Phase 4 |
| Recruiting | Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment NCT06427317 | Imperial College London | — |
| Completed | Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment NCT06095895 | Radboud University Medical Center | — |
| Withdrawn | Detection of Paracetamol Concentration in Patients Using Regular Medication- a Validation Study for a Novel Te NCT05167591 | Johanna Kujala | N/A |
| Completed | Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR NCT06725992 | Il-Yang Pharm. Co., Ltd. | Phase 1 |
| Unknown | Pharmacokinetic Profile of Rosemary Extract Supplement NCT05931341 | CJ CheilJedang | N/A |
| Completed | Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 NCT06360796 | Jiaxing AnDiCon Biotech Co.,Ltd | Phase 1 |
| Unknown | Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects NCT06277284 | Shanghai Mabgeek Biotech.Co.Ltd | N/A |
| Not Yet Recruiting | First Time Right of Vancomycin NCT05964114 | Erasmus Medical Center | N/A |
| Completed | Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China NCT06362460 | Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| Completed | Pharmacokinetic Profile of N-Acetyl Cysteine NCT06252519 | University of Memphis | N/A |
| Completed | Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience NCT06072170 | Altasciences Company Inc. | Phase 1 |
| Completed | A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinet NCT07154095 | West China Second University Hospital | Phase 1 |
| Completed | Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride NCT06822114 | Ahon Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy A NCT05949385 | Nanjing Zenshine Pharmaceuticals | Phase 1 |
| Completed | Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and NCT06497049 | Geropharm | Phase 1 |
| Completed | Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment NCT05856513 | Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| Completed | A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers C NCT05898672 | Pfizer | Phase 1 |
| Completed | SB17170 Phase1 Trial in Healthy Volunteer NCT05795192 | SPARK Biopharma | Phase 1 |
| Completed | A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants NCT05852340 | Pfizer | Phase 1 |
| Unknown | A Study of Atropine Sulfate in Healthy Chinese Volunteers NCT05855018 | Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited | Phase 1 |
| Completed | Hutrukin to Analyze Safety and PK in Healthy Volunteers NCT05098080 | XBiotech, Inc. | Phase 1 |
| Completed | Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China NCT05873426 | Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| Completed | Electrophysiological Effects of Potential QT Prolonging Drugs NCT05716854 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers NCT05847218 | RH Nanopharmaceuticals | Phase 1 |
| Recruiting | Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients NCT05755503 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | — |
| Completed | Pharmacokinetics of Two Fatty Acid Ketone Esters NCT05686083 | BHB Therapeutics, Ireland LTD | N/A |
| Active Not Recruiting | To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects NCT07030504 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 1 |
| Completed | Uptake of an Omega-3 Oil in Healthy Adults NCT05650294 | Aker BioMarine Human Ingredients AS | N/A |
| Completed | A Study to Compare Pharmacokinetics of GB1211 NCT05747573 | Galecto Biotech AB | Phase 1 |
| Unknown | Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients NCT05665478 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Completed | Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers NCT05698095 | Usona Institute | Phase 1 |
| Unknown | Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia NCT05259228 | National Taiwan University Hospital | — |
| Completed | Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midaz NCT05633147 | Cinclus Pharma Holding AB | Phase 1 |
| Completed | Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation NCT05627518 | Cinclus Pharma Holding AB | Phase 1 |
| Unknown | A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB NCT06122454 | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Phase 1 / Phase 2 |
| Completed | Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function NCT05488678 | Basilea Pharmaceutica | Phase 1 |
| Recruiting | PK/PD of Caspofungin in Children Severe Infection NCT04961593 | Children's Hospital of Fudan University | — |
| Completed | The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects NCT05517616 | Ascentage Pharma Group Inc. | Phase 1 |
| Completed | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants NCT05527834 | Basilea Pharmaceutica | Phase 1 |
| Unknown | Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip NCT05421312 | Radboud University Medical Center | Phase 4 |
| Completed | Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T NCT05509543 | Il-Yang Pharm. Co., Ltd. | Phase 1 |
| Completed | Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-A NCT05539872 | Amphastar Pharmaceuticals, Inc. | Phase 2 / Phase 3 |
| Completed | Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers NCT05569278 | GE Healthcare | Phase 1 |
| Completed | A Clinical Study With Adalimumab Biosimilar NCT06291948 | Laboratorios Richmond S.A.C.I.F. | Phase 1 |
| Completed | Food Effects on Bioavailability of MDMA in Healthy Volunteers NCT05147402 | Lykos Therapeutics | Phase 1 |
| Completed | A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablet NCT05436678 | NeuroSense Therapeutics Ltd. | Phase 1 |
| Completed | Cefiderocol Plasma Concentrations in Patients Receiving Renal Replacement Therapy NCT05373615 | Hartford Hospital | Phase 1 |
| Unknown | Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets NCT05576584 | Fujian Akeylink Biotechnology Co., Ltd. | Phase 1 |
| Unknown | Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects NCT05481385 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover De NCT06652997 | West China Second University Hospital | Phase 1 |
| Unknown | A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate NCT05469854 | Cinclus Pharma AG | Phase 1 |
| Unknown | Pharmacokinetics and Pharmacodynamics of Linezolid Continuous and Intermittent Administration NCT05801484 | Cluj Municipal Clinical Hospital | N/A |
| Completed | Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740 NCT05437094 | Cardurion Pharmaceuticals, Inc. | Phase 1 |
| Completed | An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmaco NCT05478278 | Usona Institute | Phase 1 |
| Unknown | A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects NCT05486598 | Advenchen Laboratories Nanjing Ltd. | Phase 1 |
| Completed | PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel NCT05041699 | International Partnership for Microbicides, Inc. | Phase 1 |
| Unknown | Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs G NCT05652595 | Geropharm | Phase 1 |
| Unknown | Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects NCT05381870 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Unknown | KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug NCT05373277 | Helsinki University Central Hospital | Phase 1 |
| Completed | Clinical Decision Support Tool for Vancomycin Dosing in Children NCT04911270 | University of Maryland, Baltimore | N/A |
| Completed | A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & F NCT05452785 | Journey Medical Corporation | Phase 1 |
| Completed | Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concu NCT05257447 | University of Texas Southwestern Medical Center | Phase 1 |
| Terminated | Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers NCT05460065 | NEURALIS s.a. | Phase 1 |
| Completed | Pharmacokinetics of C6 Ketone Di-ester NCT05310058 | BHB Therapeutics, Ireland LTD | N/A |
| Completed | A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects NCT05232461 | NeuroSense Therapeutics Ltd. | Phase 1 |
| Completed | The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusi NCT05253339 | Asan Medical Center | N/A |
| Unknown | Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) NCT05503147 | Ove Andersen | Phase 1 |
| Completed | Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) NCT05648799 | Geropharm | N/A |
| Completed | Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants NCT05330858 | Alumis Inc | Phase 1 |
| Completed | Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial NCT05277376 | dsm-firmenich Switzerland AG | Phase 3 |
| Completed | Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis NCT05180500 | Sharon Hillier | Phase 1 |
| Completed | Clinical Trial on Pharmacokinetics and Tolerability of AP707 NCT05267769 | CannaXan GmbH | Phase 1 |
| Completed | Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids NCT05394701 | Factors Group of Nutritional Companies Inc. | N/A |
| Completed | P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extende NCT04489134 | Rennes University Hospital | Phase 2 |
| Completed | Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin NCT05036421 | Ain Shams University | Phase 3 |
| Unknown | Pharmacokinetic Study of Continuous Infusion of Remazolam in Mechanically Ventilated Patients in ICU NCT05480787 | The First Affiliated Hospital with Nanjing Medical University | Phase 4 |
| Completed | Pharmacological Profile of Different Berberine Formulations, and Effects on Blood Sugar Levels NCT05370261 | Factors Group of Nutritional Companies Inc. | N/A |
| Completed | Pharmacological Profile of Different Quercetin Formulations NCT05611827 | Factors Group of Nutritional Companies Inc. | N/A |
| Completed | Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed an NCT05266248 | PepsiCo Global R&D | Phase 1 |
| Unknown | Natrunix Safety PK Study in Healthy Volunteers NCT05099510 | XBiotech, Inc. | Phase 1 |
| Completed | A Phase I Pharmacokinetics Study for KT07 Capsule NCT05223660 | Yiling Pharmaceutical Inc. | Phase 1 |
| Unknown | Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Tr NCT05187455 | Guangzhou General Hospital of Guangzhou Military Command | Phase 4 |
| Completed | Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers NCT05588531 | Nanjing Yoko Biomedical Co., Ltd. | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants NCT05143905 | AstraZeneca | Phase 1 |
| Completed | Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101) NCT05090280 | Ensysce Biosciences | Phase 1 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volun NCT05217732 | Nanjing Zenshine Pharmaceuticals | Phase 1 |
| Recruiting | Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors NCT05142592 | Nanjing Immunophage Biotech Co., Ltd | Phase 1 / Phase 2 |
| Completed | Single-dose AQ001S PK Study in Healthy Volunteers NCT05148312 | Aquilon Pharmaceuticals S.A. | Phase 1 |
| Unknown | Immunological Effect of Increasing Doses of Natural Peptide NCT05176678 | Natural Immune Systems Inc | N/A |
| Completed | Bioavailability of Intranasal Dexmedetomidine NCT05065775 | Turku University Hospital | Phase 4 |
| Completed | Study of DTRI-031 in Healthy Volunteers NCT05005520 | Basking Biosciences, Inc. | Phase 1 |
| Unknown | Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects. NCT05042674 | Natural Immune Systems Inc | N/A |
| Recruiting | Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies NCT04669717 | University of Geneva, Switzerland | Phase 4 |
| Completed | Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults NCT05490095 | Sovargen | Phase 1 |
| Unknown | Naldebain for Pain Control After Bariatric Surgery NCT04651361 | E-DA Hospital | Phase 2 / Phase 3 |
| Completed | To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Popul NCT04969965 | EQRx, Inc. | Phase 1 |
| Unknown | Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Stu NCT05172817 | Institute for Developing Science and Health Initiatives, Bangladesh | Phase 2 / Phase 3 |
| Completed | Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Vol NCT05124730 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | Interaction Between Cannabidiol, Meal Ingestion, and Liver Function NCT04971837 | Colorado State University | N/A |
| Completed | Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers NCT04906005 | Guerbet | Phase 1 |
| Completed | Biomarker Changes and Anxiolytic Effects-Phase 2 NCT04565145 | University of Florida | Phase 2 |
| Completed | Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit NCT04777058 | Radboud University Medical Center | — |
| Completed | Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone NCT04764630 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Pharmacokinetic Evaluation of Intranasal Nalmefene NCT04759768 | Opiant Pharmaceuticals Inc | Phase 1 |
| Withdrawn | A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHIN NCT04126044 | Pfizer | Phase 1 |
| Completed | JOTROL PK, Safety, and Food Effect Assessment NCT04668274 | Jupiter Orphan Therapeutics Inc. | Phase 1 |
| Completed | Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30 NCT06778304 | West China Second University Hospital | Phase 1 |
| Completed | Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients NCT04684381 | Emmaus Medical, Inc. | Phase 4 |
| Completed | Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration NCT05503498 | Hospital Clinic of Barcelona | — |
| Completed | Pharmacokinetics of Aqueous Dexamethasone NCT04667507 | Frank A. Bucci, Jr., M.D. | Phase 4 |
| Completed | Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults NCT04672707 | Second Affiliated Hospital of Wenzhou Medical University | Phase 1 |
| Withdrawn | Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects NCT04729088 | Biolab Sanus Farmaceutica | Phase 1 |
| Completed | Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Sub NCT05433896 | Xspray Pharma AB | Phase 1 |
| Completed | Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subje NCT05123976 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers NCT04181008 | University of Utah | EARLY_Phase 1 |
| Completed | Oral Nafamostat in Healthy Volunteers (NAF-101) NCT04406415 | Ensysce Biosciences | Phase 1 |
| Completed | A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Hea NCT04459585 | Daiichi Sankyo Co., Ltd. | EARLY_Phase 1 |
| Completed | Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048 NCT04319718 | Hillier, Sharon, PhD | Phase 1 |
| Completed | A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Partici NCT04459598 | Daiichi Sankyo Co., Ltd. | Phase 1 |
| Unknown | Antioxidant Bioavailability NCT04463030 | Natural Immune Systems Inc | N/A |
| Unknown | Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer NCT05329597 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Completed | Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administ NCT04397445 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in H NCT04435483 | AstraZeneca | Phase 1 |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products NCT04183491 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics NCT03843502 | University of Florida | Phase 1 |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists NCT04183192 | Food and Drug Administration (FDA) | Phase 1 |
| Unknown | Population Pharmacokinetics of Tigecycline in Patients Treated With ECMO NCT04724798 | Nanfang Hospital, Southern Medical University | — |
| Completed | Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors NCT04189484 | Food and Drug Administration (FDA) | Phase 1 |
| Withdrawn | Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis NCT03722381 | University of Michigan | — |
| Unknown | Population Pharmacokinetics of Fluconazole in the Treatment of Neonatal Fungal Infectious Disease NCT05775692 | Beijing Children's Hospital | — |
| Unknown | Levosimendans Pharmacokinetics in Intensive Care Patients. An Observational Study. NCT05076864 | Karolinska Institutet | — |
| Completed | A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males NCT04183517 | Syntara | Phase 1 |
| Completed | An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet NCT04176367 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 |
| Completed | Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects NCT05125640 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Inject NCT04207840 | Amphastar Pharmaceuticals, Inc. | Phase 4 |
| Terminated | PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14) NCT04142359 | Altor BioScience | — |
| Completed | Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects NCT04092751 | Scynexis, Inc. | Phase 1 |
| Completed | Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects NCT04092725 | Scynexis, Inc. | Phase 1 |
| Completed | Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vagina NCT05125627 | Joint Stock Company "Farmak" | Phase 1 |
| Unknown | Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition NCT04161404 | University of Malaya | Phase 1 |
| Unknown | Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome NCT04045171 | The Third Xiangya Hospital of Central South University | — |
| Recruiting | Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants NCT03717623 | Melbourne Health | Phase 4 |
| Unknown | Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutro NCT04250038 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Peak Plasma Levels of Bupivacaine After a Pecto-Intercostal Fascial Block Post-Sternotomy for Cardiac Surgery NCT03920904 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Completed | A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg" NCT04631874 | CTC Bio, Inc. | Phase 1 |
| Unknown | Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy NCT03672149 | Drexel University | Phase 1 |
| Unknown | Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade NCT04131218 | Guangzhou General Hospital of Guangzhou Military Command | Phase 4 |
| Unknown | Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Lap NCT05328778 | Guangzhou General Hospital of Guangzhou Military Command | Phase 4 |
| Unknown | Population PK of Antibiotics, Sedative and Analgesics, and Antiplatelet Drugs During ECMO NCT05406492 | Gachon University Gil Medical Center | — |
| Completed | Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Diffe NCT04004195 | Bayer | Phase 1 |
| Completed | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML NCT03727750 | Pfizer | Phase 4 |
| Unknown | Ceftobiprole's Cerebrospinal Fluid Penetration in Patients With External Ventricular Derivation (CEFTO-EVD) NCT04178629 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Completed | Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients NCT04023760 | University of Saskatchewan | Phase 4 |
| Completed | Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunt NCT05124717 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone NCT04295161 | Zentiva, k.s. | Phase 1 |
| Completed | Peak Plasma Levels of Bupivacaine After an Erector Spinae Block (ESP) NCT03841409 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Completed | A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers NCT04100759 | Ain Shams University | Phase 1 / Phase 2 |
| Completed | Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection NCT04219865 | Nanjing Yoko Biomedical Co., Ltd. | Phase 1 |
| Unknown | Itraconazole Pharmacokinetic With and Without Efavirenz Using the Capsule Formulation as Part of Talaromycosis NCT04031053 | Chiang Mai University | — |
| Withdrawn | Malarone Pharmacokinetics Under Simulated Physiologic Stressors of Deployment NCT03991208 | Walter Reed Army Institute of Research (WRAIR) | Phase 4 |
| Completed | Ketone Levels Achieved After Medium Chain Triglyceride (MCT) Oil NCT04389983 | University of Alberta | N/A |
| Completed | Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it NCT03953183 | Philip Morris Products S.A. | N/A |
| Recruiting | Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracos NCT03737292 | Milton S. Hershey Medical Center | Phase 4 |
| Completed | Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Vo NCT05123781 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab NCT03919448 | Laboratorios Richmond S.A.C.I.F. | Phase 1 |
| Unknown | Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients NCT03557840 | Paul M. Tulkens | N/A |
| Completed | Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients NCT03844555 | Genfit | Phase 1 |
| Completed | A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Di NCT05353686 | Pila Pharma | Phase 2 |
| Completed | Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate NCT03739294 | Bispebjerg Hospital | Phase 2 |
| Completed | A Study of Dexmedetomidine Pharmacokinetics for Preoperative Sedation NCT03800641 | Eye & ENT Hospital of Fudan University | Phase 4 |
| Completed | Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunt NCT05125575 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients NCT03765671 | Genfit | Phase 1 |
| Completed | Scavenging of Reactive Carbonyl Species by Apple Polyphenols in Human NCT03911050 | North Carolina Agriculture & Technical State University | N/A |
| Completed | Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Su NCT05967377 | Xspray Pharma AB | Phase 1 |
| Completed | Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women NCT03737656 | Grünenthal GmbH | Phase 1 |
| Completed | Pharmacokinetics of Intravenous, Rectal, Intravesical, Vaginal, and Transdermal Melatonin in Healthy Female Vo NCT03519750 | Dennis Bregner Zetner | Phase 1 |
| Unknown | A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese NCT03715114 | Shanghai Greenvalley Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients NCT03145272 | Mahidol University | Phase 4 |
| Completed | Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat NCT03789032 | Akebia Therapeutics | Phase 1 |
| Completed | The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflo NCT03895229 | Ain Shams University | Phase 1 |
| Completed | Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects NCT03629067 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Unknown | Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population NCT03633760 | A.Menarini Asia-Pacific Holdings Pte Ltd | Phase 1 |
| Completed | Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Partic NCT03614455 | Daiichi Sankyo | EARLY_Phase 1 |
| Completed | Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Sub NCT05125549 | Joint Stock Company "Farmak" | Phase 1 |
| Completed | Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis NCT03612180 | University of Michigan | — |
| Unknown | Pharmacokinetic (PK)Research on Chinese Children of Hemophilia NCT03622476 | Beijing Children's Hospital | Phase 4 |
| Completed | Safety and Pharmacokinetics of an Extract of Naringenin NCT03582553 | Pennington Biomedical Research Center | EARLY_Phase 1 |
| Completed | Renal Function Assessment in Critically Ill Children NCT05179564 | University Hospital, Ghent | N/A |
| Unknown | A Phase 1 Study of Tegoprazan on Healthy Male Volunteers NCT03530228 | HK inno.N Corporation | Phase 1 |
| Completed | Rogaratinib (BAY1163877) Human Mass Balance Study NCT03484585 | Bayer | Phase 1 |
| Completed | VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment NCT03690362 | Venatorx Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil NCT03480243 | UCB Biopharma S.P.R.L. | Phase 1 |
| Unknown | Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive NCT03440216 | Université Catholique de Louvain | N/A |
| Unknown | Kinetic Time Courses of Bisphenol-S in Volunteers NCT03340168 | Université de Montréal | N/A |
| Completed | Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir NCT03631316 | Luis Eduardo Morales Buenrostro | N/A |
| Completed | Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With A NCT03396445 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid NCT03309657 | Royal Brisbane and Women's Hospital | Phase 1 / Phase 2 |
| Unknown | Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Pa NCT03258099 | Cui Yimin | — |
| Completed | Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration NCT03324061 | Eagle Pharmaceuticals, Inc. | Phase 1 |
| Completed | Pharmacokinetics of Antiepileptics in Patients on CRRT NCT03632915 | University of Maryland, Baltimore | — |
| Completed | Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001) NCT03326986 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P NCT03369340 | Philip Morris Products S.A. | N/A |
| Completed | Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russ NCT04501250 | Geropharm | N/A |
| Unknown | Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric NCT03337581 | Chinese Medical Association | Phase 4 |
| Completed | Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers NCT03522012 | Mycenax Biotech Inc. | Phase 1 |
| Unknown | Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patie NCT03258151 | Cui Yimin | — |
| Unknown | Pharmacokinetics in Extracorporeal Membrane Oxygenation NCT03766282 | China-Japan Friendship Hospital | — |
| Terminated | Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns NCT03002506 | Texas Tech University Health Sciences Center | Phase 4 |
| Unknown | Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers NCT03252067 | Beijing Tongren Hospital | Phase 1 |
| Completed | Beta-lactam Pharmacokinetics in Secondary Care NCT03033394 | Imperial College London | — |
| Withdrawn | Pharmacokinetics Study of Eplerenone Coated Tablets NCT02957435 | Biolab Sanus Farmaceutica | Phase 1 |
| Unknown | Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants NCT03161496 | Cui Yimin | — |
| Completed | Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic I NCT03767036 | Grünenthal GmbH | Phase 1 |
| Unknown | Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor NCT03161002 | Cui Yimin | — |
| Completed | Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Ad NCT03145038 | Bayer | Phase 1 |
| Completed | Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects NCT03198624 | Nxera Pharma UK Limited | Phase 1 |
| Completed | Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamid NCT03135951 | Spectrum Pharmaceuticals, Inc | Phase 1 |
| Completed | Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus NCT03083782 | Thomas Jefferson University | Phase 1 |
| Completed | CiPA Phase 1 ECG Biomarker Validation Study NCT03070470 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (C NCT03136770 | Seoul National University Hospital | N/A |
| Completed | Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation NCT02968576 | University of Colorado, Denver | N/A |
| Completed | Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen NCT02974361 | Oxford Pharmascience Ltd | Phase 1 |
| Completed | Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects NCT02957396 | Bayer | Phase 1 |
| Completed | Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers NCT02956109 | Bayer | Phase 1 |
| Completed | Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for O NCT03011463 | Dr. R. Pfleger Chemische Fabrik GmbH | Phase 1 |
| Recruiting | Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: NCT03529617 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201 NCT02894385 | Bayer | Phase 1 |
| Recruiting | Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) NCT06426836 | University Hospital, Ghent | N/A |
| Completed | Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of C NCT02820935 | Celgene Corporation | Phase 1 |
| Completed | Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean NCT02802735 | Amgen | Phase 1 |
| Completed | Evaluation of a Novel PET Radioligand to Image OGA NCT03632226 | National Institute of Mental Health (NIMH) | — |
| Completed | A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects NCT02790684 | Daiichi Sankyo | Phase 1 |
| Completed | A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects NCT02790671 | Daiichi Sankyo | Phase 1 |
| Completed | Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration NCT03012763 | University Medicine Greifswald | Phase 1 |
| Completed | To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects Af NCT02673567 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| Completed | Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Orga NCT02671097 | Bayer | Phase 1 |
| Completed | Pentoxifylline PKB171 Gel in Healthy Females Volunteers NCT07017114 | Prokrea BCN, S.L. | Phase 1 |
| Completed | Avenanthramide and Saponin Bioavailability in Oat Bran NCT04335435 | North Carolina Agriculture & Technical State University | N/A |
| Completed | Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA) NCT03967964 | Laboratorios Andromaco S.A. | Phase 1 |
| Completed | A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD NCT02512575 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects NCT02601625 | AstraZeneca | Phase 1 |
| Withdrawn | A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Heal NCT02560363 | AstraZeneca | Phase 1 |
| Completed | Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers NCT02668367 | Biota Pharmaceuticals, Inc. | Phase 1 |
| Completed | The Safety and Pharmacokinetics of Primapur and Gonal-f NCT03857230 | IVFarma LLC | Phase 1 |
| Completed | Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaqui NCT02568098 | University of Oxford | Phase 1 |
| Completed | The Pharmacokinetics of 12 Week Continuous Patch Use NCT02585999 | Boston Medical Center | N/A |
| Completed | Bioelectrical Impedance Analysis as a Bedside Tool to Estimate Volume of Distribution of Hydrophilic Antimicro NCT03410771 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | A Pharmacokinetics Study of Intravenous Ascorbic Acid NCT02534753 | McGuff Pharmaceuticals, Inc. | Phase 1 |
| Completed | Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers NCT02558413 | Biota Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Hea NCT02484729 | AstraZeneca | Phase 1 |
| Completed | Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac NCT03766984 | Grünenthal GmbH | Phase 1 |
| Completed | Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release NCT02436577 | AstraZeneca | Phase 1 |
| Completed | Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women NCT02386488 | H. Lundbeck A/S | Phase 1 |
| Completed | Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When D NCT02359045 | AstraZeneca | Phase 1 |
| Completed | Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Unde NCT02367027 | Bayer | Phase 1 |
| Completed | Phase I Study PK Study With OXP005 and Naprosyn NCT02351024 | Oxford Pharmascience Ltd | Phase 1 |
| Completed | PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants NCT02306915 | Merckle GmbH | Phase 1 |
| Completed | A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers NCT02272764 | Alkermes, Inc. | Phase 1 |
| Completed | Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED) NCT02242006 | Ottawa Hospital Research Institute | — |
| Completed | Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers NCT02215941 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| Completed | An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal NCT02169804 | Repros Therapeutics Inc. | Phase 1 |
| Completed | A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics NCT02233972 | Jiangsu Kanion Pharmaceutical Co., Ltd | Phase 4 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese P NCT02209506 | Takeda | Phase 1 |
| Completed | A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects NCT02191462 | KGK Science Inc. | Phase 1 |
| Completed | Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towar NCT02170038 | Bayer | Phase 1 |
| Completed | Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People NCT02147392 | National Institute of Mental Health (NIMH) | EARLY_Phase 1 |
| Completed | The Effect of Low Furanocoumarin Grapefruit Hybrid Juice Consumption on Midazolam Pharmacokinetics NCT02117869 | University of Florida | Phase 4 |
| Completed | Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block NCT02308748 | Food and Drug Administration (FDA) | Phase 1 |
| Completed | Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentration NCT02169713 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin NCT02097953 | University of Utah | EARLY_Phase 1 |
| Completed | Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokineti NCT03683511 | Nantes University Hospital | — |
| Completed | Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Auto NCT07113587 | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | Phase 2 / Phase 3 |